High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease

The immunomodulatory potential and low incidence of severe side effects of high-dose intravenous immunoglobulin (IVIg) treatment led to its successful application in a variety of dermatological autoimmune diseases over the last two decades. IVIg is usually administered at a dose of 2 g per kg body w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Jochen H. O., Enk, Alexander H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579842/
https://www.ncbi.nlm.nih.gov/pubmed/31244821
http://dx.doi.org/10.3389/fimmu.2019.01090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579842/
https://www.ncbi.nlm.nih.gov/pubmed/31244821
http://dx.doi.org/10.3389/fimmu.2019.01090

Ejemplares similares